Coronavirus impact: 2 Oct – a cheap technology play to close the week
A provider of software for financial markets covered in our update here looks compelling value and could be on the cusp of meaningful growth.
EKF Diagnostics: looking good, but what next?Much like every business touching the Covid-19 testing space, shares in EKF Diagnostic (LON:EKF), the global medical manufacturer of point-of-care and central lab devices and chemistry reagents, have had an excellent run over recent months. The latest trading update confirmed that that full year performance remains in-line with management expectations, which have already been revised upwards several times this year. While their PrimeStore MTM COVID-19 sample collection device has been attracting all the interest up to now, the Group has also seen a significantly improved performance in the core business with October expected to…